Research activities are focussed on a greater understanding of the molecular interactions and development of unique genetic therapies that can be applied for the detection and treatment of highly aggressive metastatic disease.
Research activities are focussed on the design and synthesis of nanotechnologies as local and systemic delivery systems for DNA, RNAi, miRNA, and Au nanoparticle therapies.
Research activities are focussed on the development of novel strategies for the detection, characterisation and inhibition of proteases implicated in chronic diseases including respiratory, cardiovascular, cancer and infection with an emphasis on ion channel modulation, inflammatory microenvironments and immune signalling.
Research activities are focussed on the isolation and characterisation of bioactive peptides derived from animal venoms in order to discover novel antimicrobial, anticancer, antidiabetic, antihypertensive and immunostimulating therapeutic agents.
Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.
Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11